Abstract Multiple prostate cancer (PCa) risk-related loci have been discovered by genome-wide association studies (GWAS) based on case-control designs. However, GWAS findings may be confounded by population stratification if cases and controls are inadvertently drawn from different genetic backgrounds. In addition, since these loci were identified in cases with predominantly sporadic disease, little is known about their relationships with hereditary prostate cancer (HPC). The association between seventeen reported PCa susceptibility loci was evaluated with a family-based association test using 1,979 hereditary PCa families of European descent collected by members of the G. Jin and L. Lu contributed equally to this work.
International Consortium for Prostate Cancer Genetics, with a total of 5,730 affected men. The risk alleles for 8 of the 17 loci were significantly over-transmitted from parents to affected offspring, including SNPs residing in 8q24 (regions 1, 2 and 3), 10q11, 11q13, 17q12 (region 1), 17q24 and Xp11. In subgroup analyses, three loci, at 8q24 (regions 1 and 2) plus 17q12, were significantly overtransmitted in hereditary PCa families with five or more affected members, while loci at 3p12, 8q24 (region 2), 11q13, 17q12 (region 1), 17q24 and Xp11 were significantly over-transmitted in HPC families with an average age of diagnosis at 65 years or less. Our results indicate that at least a subset of PCa risk-related loci identified by case-control GWAS are also associated with disease risk in HPC families.
Introduction
Genome-wide association studies (GWAS) have succeeded in identifying low penetrance genetic risk factors that account for differing proportions of the hereditary variance associated with complex diseases (Manolio 2010) . Using a GWAS approach, several hundred thousand to more than a million single nucleotide polymorphisms (SNPs) are assayed in thousands of individuals to compare the allele frequencies between the cases and the controls for each SNP (Hardy and Singleton 2009) . Cases are generally a set of individuals who have been diagnosed with disease by a certain point in time, while controls are unaffected as of a particular reference date. One or more additional casecontrol studies are generally needed to confirm the GWAS findings, as the risk of false positives is appreciable. Although reproducibility in multiple independent study populations is a strong argument for the existence of disease-associated SNPs, population stratification between cases and controls due to population admixture or natural selective pressure resulting in false-positive associations remains a concern (Price et al. 2010 ). In addition, it is critical to know if variants identified by studies of individuals from the general population are associated with disease risk among high-risk families.
Prostate cancer (PCa) has been extensively studied using GWAS, and the results have identified and replicated multiple risk-related SNPs (Amundadottir et al. 2006; Duggan et al. 2007; Eeles et al. 2008; Gudmundsson et al. 2007a, b; Thomas et al. 2008; Yeager et al. 2007 ). However, most of these variants were identified in case-control datasets in which there may have been the possibility of population stratification. Thus, it is of interest to further assess these findings in family-based studies. In addition, subjects participating in the reported case-control studies were generally recruited from the general population, and thus primarily represent sporadic cancer cases. Although familial cases have been included in some GWAS studies (Eeles et al. 2008) , less is known about the relative importance of most of the risk alleles in high-risk or hereditary prostate cancer (HPC) families. In the present study, we sought to assess whether the genetic markers identified by GWAS are also relevant for HPC families. To address this question, we conducted a large family-based association study that included 1,979 Caucasian HPC families collected by members of the International Consortium for Prostate Cancer Genetics (ICPCG) to evaluate 17 loci that demonstrated a previous association with PCa in GWAS.
Subjects and methods

Study population
The ICPCG study population has been described in detail previously Xu et al. 2005 Each group within the ICPCG recruited its population via different methods of pedigree ascertainment and confirmation of PCa diagnosis . Nevertheless, there was a general consensus that affected individuals were all defined as men affected with PCa that had been confirmed by either medical records or death certificates. The status of self-or relative-reported men without either medical records or death certificate confirmation was considered as ''unknown''. In addition, the affection status of all men without a diagnosis of PCa was coded as ''unknown'', regardless of whether they had undergone screening for PCa. Hence, all analyses were based on the sharing of marker genotypes among affected men, with no consideration of phenotype for the remaining subjects. In total, 2,068 PCa families were collected by the ICPCG. After 89 families with African, Asian or other nonCaucasian ancestry (56, 15 and 18 families, respectively) were excluded from these analyses, the remaining 1,979 families with Caucasian ancestry were included in this study (Table 1) . These families included a total of 5,730 affected members. Research protocols and study documentation were approved by each group's Institutional Review Board.
SNPs selection
One SNP was selected from each of the 17 loci that had been shown to be significantly associated with PCa risk in previous GWAS (P \ 10 -8 ) (Amundadottir et al. 2006; Duggan et al. 2007; Eeles et al. 2008; Gudmundsson et al. 2007a, b; Thomas et al. 2008; Yeager et al. 2007 ) and subsequently in a follow-up fine-mapping study (Sun et al. 2008b ). As shown in Table 2 , the loci included three independent positions at 8q24, two at 17q12, and one SNP each at chromosome 2p15, 3p12, 6q25, 7p15, 7p21, 9p13, 10q11, 10q26, 11q13, 17q24, 19q13 , and Xp11. Moreover, seven additional SNPs at three independent regions of 8q24 (Witte 2007) were also included: two from region 1, three from region 2 and two from region 3. In addition, we included one SNP (rs979200) that was centromeric to the three at 8q24 that was found to be associated with PCa risk in finemapping studies (Salinas et al. 2008; Sun et al. 2008a ).
Genotyping
All samples were coordinated and genotyped using the MassARRAY iPLEX (Sequenom, Inc., San Diego, CA, USA) at the Center for Cancer Genomics, Wake Forest University. Briefly, PCR assays were performed in a total volume of 5 lL that contained 10 ng of genomic DNA, 3.5 mM of MgCl 2 , 0.5 U of HotStarTaq polymerase (QIA-GEN Inc., Valencia, CA, USA), 0.5 mM of each dNTP (Invitrogen, Carlsbad, CA, USA), and 0.06 lM of each primer. The PCR cycling conditions were 94°C for 15 min; followed by 45 cycles of 94°C for 20 s, 56°C for 30 s, and 72°C for 1 min; followed by a final extension at 72°C for 3 min. Shrimp alkaline phosphatase (SAP) treatments were performed in a total volume of 7 lL that contained the entire PCR mixture and 0.3 U of SAP, with incubation at 37°C for 40 min. The iPLEX extension reactions were performed in a total volume of 9 lL that included the entire SAP reaction and 19 iPLEX termination mix, 19 iPLEX enzyme, and 5.625 lM of each extension primer. The samples were desalted with 6 mg of clean resin and then dispensed to a SpectroCHIP. The chips were scanned using the MALDI-TOF MS system, and the genotypes were analyzed by the MassARRAY Typer 3.4 (Sequenom Inc.). Duplicates and negative controls were included in each 96-well plate to ensure quality control (QC). Genotyping was performed by technicians blinded to sample status. The average concordance rate was [98% for the 25 SNPs.
Statistical methods
To test the linkage or linkage disequilibrium (association) of genotypes with HPC, data from nuclear families and (or) sibships were used to perform a family-based association test (FBAT). FBAT evaluates whether particular alleles are transmitted from parents to affected offspring in a proportion that is different from that expected under the null hypothesis of no association between marker and disease. The empirical variance estimator in FBAT was used to perform a valid test of association, accounting for the correlation of transmitted alleles among multiple affected individuals in the same family due to coinheritance. FBAT analysis was carried out using the appropriate software .
Results
The characteristics of the 1,979 ICPCG Caucasian HPC families are summarized in Table 1 . More than 15% of families (305/1,979) had five or more members affected with PCa. Among 1,690 families with available information on age at prostate cancer diagnosis, 796 families (47.1%) had an average age at diagnosis B65 years.
As shown in Table 2 , 7 of the 17 loci that were originally associated with PCa risk in previous GWAS showed a statistically significant association based on the family-based association tests. These included 8q24 region 2 (rs16901979, P = 0.031), 8q24 region 3 (rs6983267, P = 0.017), 10q11 (rs10993994, P = 6.70 9 10 -5 ), 11q13 (rs10896449, P = 2.31 9 10 -3 ), 17q12 region 1 (rs4430796, P = 0.010), 17q24 (rs1859962, P = 1.03 9 10 -4 ) and Xp11 (rs5945619, P = 6.92 9 10 -4 ). Among eight additional SNPs selected at 8q24, three regions demonstrated one significant SNP each (region 1: rs4242382, P = 0.011; region 2: rs1016343, P = 0.020; and region 3: rs7837328, P = 0.019). For all of a The average age of onset for affected members was not available (NA) in the University of Michigan group the significant SNPs, the direction of association was consistent with the original reports, i.e., the over-transmitted alleles from parents to affected men (S-E(S)[0) were the same as the risk alleles reported in the original studies (Amundadottir et al. 2006; Duggan et al. 2007; Eeles et al. 2008; Gudmundsson et al. 2007a, b; Thomas et al. 2008; Yeager et al. 2007 ).
To evaluate the role of these selected SNPs in subsets of families characterized by number of affected individuals or early mean age at diagnosis, we performed an FBAT analysis, specifically, in families with five or more affected men, or those with an average age at diagnosis of 65 years or less. As shown in Table 3 , among 305 families with five or more affected individuals, previously reported risk alleles for five SNPs in three loci were significantly over-transmitted from parents to affected men, including four SNPs found to be significant in all families: 8q24 region 1 (rs4242382: P = 0.010), 8q24 region 2 (rs16901979: P = 0.034; and rs1016343: P = 0.010), and 17q24 (rs1859962: P = 1.62 9 10 -3 ), and one additional SNP at 8q24 region 1 (rs10091054: P = 0.045). For 796 families with average age of diagnosis B65 years, the risk alleles for six SNPs were found to be significantly over-transmitted, including five SNPs at 8q24 region 2 (rs16901979: P = 0.023), 11q13 (rs10896449: P = 0.010), 17q12 region 1 (rs4430796: P = 0.012), 17q24 (rs1859962: P = 8.01 9 10 -4 ) and Xp11 (rs5945619: P = 4.70 9 10 -3 ) that were also observed to be significant in all families, and one additional SNP at 3p12 (rs2660753: P = 0.037).
Discussion
In this study, we examined PCa risk-related loci that were identified in previous GWAS using a family-based association approach based on 1,979 HPC families of Caucasian descent collected by the ICPCG. Family-based association methods evaluate whether particular alleles are transmitted from parents to affected offspring in a proportion that is different from that expected under the null hypothesis of no association between marker and disease (Lunetta et al. 2000) . Among 17 loci analyzed in this study, risk alleles of eight loci were observed to be significantly over-transmitted from parents to affected offspring. Because family-based studies utilize non-transmitted alleles from the same parents as the control, these methods are not susceptible to population stratification. Therefore, the results from our study provide more compelling evidence that these eight loci are truly associated with risk of PCa. This study also demonstrates that typically low penetrance variants identified from GWAS studies are also important for PCa in HPC families.
Family-based studies may be ideal for validating previously identified genetic risk factors from case-control studies by the absence of susceptibility to false-positive results due to population stratification. GWAS studies generally identify common variants of comparatively lower penetrance, while linkage-based family studies identify rare highly penetrant variants. The nine loci associations that were not replicated in this FBAT analysis may simply represent variants of low penetrance. Our study also does not distinguish which of several possible mutations may be causative. Therefore, there may exist mutations in a gene that are weakly penetrant, and that identify a given locus in a GWAS, while a few rare and highly penetrant mutations, such as loss-of-function mutations, segregate in a subset of families and lead to validation in the FBAT analysis. These approaches are also efficient when utilizing the large family-based samples that have been collected in the past for genetic linkage studies. In the present study, 1,979 families with a total of 5,730 affected members collected from 12 groups in the ICPCG were analyzed. However, the diminished statistical power resulting from the matching of transmitted with non-transmitted alleles from the same family is a limitation of this approach (Lange et al. 2008) . We cannot formally exclude the possibility that the remaining nine loci, which were originally associated with PCa risk in case-control studies (Amundadottir et al. 2006; Duggan et al. 2007; Eeles et al. 2008; Gudmundsson et al. 2007a, b; Thomas et al. 2008; Yeager et al. 2007) , and for which significant differences between observed and expected allele transmissions were not observed in the current FBAT analyses, were not associated with disease risk in HPC families. In addition to the validation of findings reported in previous studies, this study provides another level of confirmatory evidence supporting the importance of genetic risk factors in HPC. A GWAS performed by Eeles et al. (2008) using familial or early onset cases reported that genetic variants at 3p12, 6q25, 7q21, 8q24 region 1, region 2 and region 3, 10q11, 11q13, 17q12, 17q24, 19q13 and Xp11 were observed to have genome-wide significant associations with PCa risk, suggesting that these loci may account for some portion of the heritability in families with excess PCa. Our study confirms a role of loci at 8q24 region 1, region 2 and region 3, 10q11, 11q13, 17q12, 17q24, and Xp11, but not at 3p12, 6q25, 7q21 and 19q13.
We further focused on families with larger numbers of affected men as well as those with early onset PCa cases and found three and six loci with significant associations, respectively. Generally, families with such characteristics may be more likely to reflect an important role for genetic factors in disease etiology. However in this study, we noted that some significant loci were not involved in the larger or early onset families. This is not surprising, as GWAS are not aimed at identifying rare highly penetrant loci that would be expected to characterize such families. Thus, these loci may not contribute to the heritability of multiple or early onset PCa. Alternatively, our results may reflect limitations in statistical power associated with the data set. Therefore, we propose that the results based on significantly over-transmitted risk alleles in multiple or early onset families, but not all families, should be interpreted with caution. Amundadottir et al. (2006) originally identified genetic variants at 8q24 to be associated with PCa risk using a genome-wide linkage scan in 323 extended PCa families followed by two case-control groups of European ancestry and one African American group. Subsequent studies have consistently confirmed these findings and suggested at least three distinct regions within 8q24 that are independently associated with PCa risk (i.e., regions 1, 2 and 3, Table 2 ) (Gudmundsson et al. 2007a; Haiman et al. 2007; Yeager et al. 2007 ). In the current study, we genotyped three to four SNPs at each region, and found a significant association for at least one SNP in each locus. Interestingly, the SNP rs16901979 at 8q24 region 2 was also significantly associated with PCa risk in families with five or more affected men, or those with an average age at diagnosis of 65 years or less. These results suggest that genetic variants at three independent regions of 8q24 are all implicated in the inherited risk of PCa in HPC families.
Our study has strengths and limitations. The familybased association design is a strength, offering the ability to reduce the risk of false-positive findings due to population stratification. Another strength is the large number of HPC families included in the analyses that yielded a measure of statistical power that reduces the inefficiency of family-based association studies when considering the matching of transmitted with non-transmitted alleles in the same family. A limitation is the potential for heterogeneous genetic and environmental influences in PCa families collected from multiple locations across the US and Europe.
In summary, we confirmed multiple PCa risk-associated loci identified in GWAS or follow-up studies using a family-based association design. Our results suggest that these regions associated with sporadic PCa risk are not due to population stratification or admixture, and may account for a proportion of the inherited risk associated with HPC families. Finally, this study demonstrates the value of utilizing existing familial samples, originally collected for the purpose of linkage, to identify findings from a GWAS that are relevant for a disease in high-risk families.
Partial support was provided by NIH P50 CA69568, NIH R01 CA79596 (to Kathleen Cooney), and the University of Michigan
